Evonik Industries (FRA:EVK) received a €24.50 ($28.49) target price from investment analysts at JPMorgan Chase & Co. in a research report issued on Thursday. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 6.01% from the stock’s current price.
EVK has been the subject of a number of other reports. Goldman Sachs Group set a €29.50 ($34.30) price target on Evonik Industries and gave the company a “neutral” rating in a report on Tuesday, November 13th. Barclays set a €34.00 ($39.53) price target on Evonik Industries and gave the company a “buy” rating in a report on Tuesday, November 6th. Berenberg Bank set a €35.00 ($40.70) price target on Evonik Industries and gave the company a “buy” rating in a report on Wednesday, November 7th. UBS Group set a €22.00 ($25.58) price target on Evonik Industries and gave the company a “sell” rating in a report on Monday, January 7th. Finally, Societe Generale set a €40.00 ($46.51) price target on Evonik Industries and gave the company a “buy” rating in a report on Tuesday, November 6th. Four equities research analysts have rated the stock with a sell rating, six have issued a hold rating and twelve have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of €31.52 ($36.66).
EVK stock opened at €23.11 ($26.87) on Thursday. Evonik Industries has a fifty-two week low of €26.78 ($31.14) and a fifty-two week high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Featured Article: How to invest in a bear market
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.